FDA recall record

HydrOXYzine HCI Tablets USP 10 mg, 100 count bottles recall — FDA D-1030-2014

Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.

Class IIclassification
D-1030-2014official record ID
Jan 29, 2014report date

Recall record at a glance

Official recordD-1030-2014
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmKVK-Tech, Inc.
Report dateJan 29, 2014
Recall initiation dateDec 11, 2013
Quantity14664 bottles
LocationNewtown, PA, United States

Official product description

HydrOXYzine HCI Tablets USP 10 mg, 100 count bottles, Rx only. Mfd by KVK-TECH, INC, Newtown, PA 18940. NDC #10702-010-01.

Why the product was recalled

Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.

Distribution information

Nationwide, including Puerto Rico to wholesale distributors for sale to retail establishments.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.